Uchida N, Combs J, Chen S, Zanjani E, Hoffman R, Tsukamoto A
SyStemix Inc, Palo Alto, CA 94304, USA.
Blood. 1996 Aug 15;88(4):1297-305.
Human bone marrow (BM) CD34+ cells were stained with the vital dye, rhodamine 123 (Rh123), and analyzed for their biological properties based on the level of dye retention. Heterogeneous rhodamine staining is seen within the CD34+ population, and the staining patterns differ dramatically between fetal BM (FBM), adult BM (ABM) and mobilized peripheral blood (MPB). Kinetic analysis of the efflux of Rh123 from ABM CD34+ cells showed that efflux of Rh123 was most rapid from the most primitive Thy-1+ subset. The efflux of Rh123 could be inhibited by verapamil, suggesting that rhodamine efflux from primitive hematopoietic cells is primarily due to the P-glycoprotein (P-gp) pump or another intracellular transport system affected by verapamil. When four CD34+ subpopulations were plated onto SyS1 BM stromal cell cocultures after 1 to 2 weeks, only wells plated with CD34+ Thy-1+Rh123lo (low-level Rh123 retention) or CD34+Thy-1+Rh123mid (mid-level Rh123 retention) cells maintained greater than 50% of cells in an uncommitted CD34+33- stage. CD34+Lin- (lineage-negative) cells were fractionated based on Rh123 dye staining into Rh123hi (high-level Rh123 retention), Rh123mid, and Rh123lo and deposited as single cells into long-term SyS1 BM stromal cell cultures. The Rh123mid fraction had immense early proliferative activity in vitro, but lost the ability to form cobblestone areas after 5 to 6 weeks in culture. In contrast, the Rh123lo fraction proliferated more slowly but sustained long-term in vitro hematopoiesis as evidenced by continued cobblestone area-forming cells (CAFC) activity for at least 6 weeks. The Rh123hi fraction showed a plating efficiency similar to that of the Rh123lo or Rh1123mid fractions but did not extensively proliferative in vitro and did not show evidence of CAFC activity. We predicted from these in vitro results that the Rh123lo subsets possesses long-term engrafting potential. Indeed, on transplantation into the SCID-hu bone assay, all long-term engrafting potential and multilineage differentiation potential resided within the Rh123lo-mid but not Rh123hi subset. Furthermore, human marrow subpopulations derived from chimeric sheep after in utero transplantation with CD34+Thy-1+Lin- cells were reisolated based on Rh123 staining. Again, CD34+Lin- subsets showing Rh123lo-mid had long-term growth in culture, whereas Rh123hiCD34+Lin- cells did not. These results show that, after injection of CD34+Thy-1+Lin- cells into an in utero microenvironment, primitive CD34+ cells maintain a Rh123 phenotype that correlates with their in vitro CAFC activity. Thus, Rh123 staining is an effective way to define functional subsets of primitive hematopoietic cell populations.
人骨髓(BM)CD34+细胞用活性染料罗丹明123(Rh123)染色,并根据染料保留水平分析其生物学特性。在CD34+群体中可见异质性罗丹明染色,且胎儿骨髓(FBM)、成人骨髓(ABM)和动员外周血(MPB)之间的染色模式差异显著。对ABM CD34+细胞中Rh123流出的动力学分析表明,Rh123从最原始的Thy-1+亚群流出最快。维拉帕米可抑制Rh123的流出,这表明原始造血细胞中罗丹明的流出主要归因于P-糖蛋白(P-gp)泵或另一种受维拉帕米影响的细胞内转运系统。将四个CD34+亚群接种到SyS1骨髓基质细胞共培养物上1至2周后,只有接种了CD34+Thy-1+Rh123lo(低水平Rh123保留)或CD34+Thy-1+Rh123mid(中等水平Rh123保留)细胞的孔中,超过50%的细胞维持在未分化的CD34+33-阶段。基于Rh123染料染色将CD34+Lin-(谱系阴性)细胞分为Rh123hi(高水平Rh123保留)、Rh123mid和Rh123lo,并作为单细胞接种到长期SyS1骨髓基质细胞培养物中。Rh123mid部分在体外具有巨大的早期增殖活性,但在培养5至6周后失去形成鹅卵石区域的能力。相比之下,Rh123lo部分增殖较慢,但能维持长期体外造血,至少6周内持续有鹅卵石区域形成细胞(CAFC)活性证明了这一点。Rh123hi部分的接种效率与Rh123lo或Rh1123mid部分相似,但在体外没有广泛增殖,也没有显示出CAFC活性的证据。我们从这些体外结果预测,Rh123lo亚群具有长期植入潜力。事实上,在移植到SCID-hu骨试验中,所有长期植入潜力和多谱系分化潜力都存在于Rh123lo-mid而非Rh123hi亚群中。此外,基于Rh123染色重新分离了经子宫内移植CD34+Thy-1+Lin-细胞后嵌合羊来源的人骨髓亚群。同样,显示Rh123lo-mid的CD34+Lin-亚群在培养中有长期生长,而Rh123hi CD34+Lin-细胞则没有。这些结果表明,将CD34+Thy-1+Lin-细胞注射到子宫内微环境后,原始CD34+细胞维持一种与体外CAFC活性相关的Rh123表型。因此,Rh123染色是定义原始造血细胞群体功能亚群的有效方法。